[go: up one dir, main page]

Thorsby, 1969 - Google Patents

HL—A Antigens and Genes-I. A Study of Unrelated Norwegians

Thorsby, 1969

Document ID
4637988658975493241
Author
Thorsby E
Publication year
Publication venue
Vox Sanguinis

External Links

Snippet

To obtain information about the genetic basis of the HL-A system, 299 unrelated Norwegians were examined with HL-A antisera. The results indicated that the HL-A antigens are determined by multiple mutually exclusive genes at two sub-loci, the LA sub-locus and the 4 …
Continue reading at karger.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells

Similar Documents

Publication Publication Date Title
Timonen et al. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells
Raff et al. Macrophage heterogeneity in man. A subpopulation of HLA-DR-bearing macrophages required for antigen-induced T cell activation also contains stimulators for autologous-reactive T cells.
Wallis et al. Human monocyte adherence to cultured vascular endothelium: monoclonal antibody-defined mechanisms.
Kissmeyer-Nielsen et al. Human transplantation antigens
Figdor et al. Isolation of functionally different human monocytes by counterflow centrifugation elutriation
Moraes et al. A new antigen system expressed in human endothelial cells
EP0289896B1 (en) A simplified method for the preparation of human lymphokine activated killer cells
Duquesnoy et al. Multiscreen serum analysis of highly sensitized renal dialysis patients for antibodies toward public and private class I HLA determinants: implications for computer-predicted acceptable and unacceptable donor mismatches in kidney transplantation
Lopez et al. Phylogenetic studies on T cells: I. Lymphocytes of the shark with differential response to phytohemagglutinin and concanavalin A
Thorsby HL—A Antigens and Genes-I. A Study of Unrelated Norwegians
Gladwin et al. Identification of mRNA for PDGF B‐chain in human megakaryocytes isolated using a novel immunomagnetic separation method
Bruger et al. Protocol to assess the suppression of T-cell proliferation by human MDSC
JP5295950B2 (en) Methods and reagents for detecting susceptibility to graft-versus-host disease or transplant-related death
EP1019546B1 (en) Methods for measurement of lymphocyte function
Amos Genetic and antigenetic aspects of human histocompatibility systems
Thorsby et al. HL-A Antigens and Genes-III. Production of HL-A Typing Antisera of Desired Specificity
Thorsby et al. New HL-A Alleles
Van Rood et al. Permissible mismatches, acceptable mismatches and tolerance: new trends in decision making
Thorsby et al. Lymphocytotoxic antisera of limited iso-specificity after skin grafting in man
Sibbitt Jr et al. Impaired release of a soluble natural killer cytotoxic factor in systemic lupus erythematosus
Greve et al. Flow cytometry in transfusion medicine: development, strategies and applications
Hallberg In Vitro Cytotoxicity of Human Lymphocytes: Reduction of the Lymphocyte Cytotoxicity Induced by Antibodies or Phytohemagglutinin by Removing Immune‐Complex‐Binding Cells
Thorsby HL-A Antigens and Genes-II. Studies of the Antigen MH (= HL-A5) of the 4 Sub-locus
Reittie et al. Differential recovery of phenotypically and functionally distinct circulating antigen-presenting cells after allogeneic marrow transplantation
Dausset et al. Role of Ia-like products of the main histocompatibility complex in conditioning skin allograft survival in man